The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

Last month, the Food and Drug Administration approved that molecule, now called Journavx, as a treatment for the sharp, short-lived “acute” pain usually felt after an accident or a surgery.

Journavx can be taken with ibuprofen for its anti-inflammatory effects. The prescription medication is not in pharmacies yet, but it maybe there by the end of February. Click here to report a typo.

Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, ...

The FDA approved Journavx on Thursday following a pair of clinical trials on 874 participants with moderate to severe acute pain following abdominoplasty — commonly known as a "tummy tuck ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...